Richard D Morgan

This inventor holds 33 USPTO granted patents and 3 published patent applications and 2 EPO patents, primarily in Restriction Endonucleases. Top assignees: New England Biolabs, Inc., Other. Active years: 1991-2025.

USPTO Granted Patents = 33 (Patent Applications = 3)

% Patents Active = 78.8

EPO Patents = 2 (Patent Applications = 11)

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 69(Granted Patents)

Location History:

Manchester, MA (US) (1991 - 1992)
Middletown, MA (US) (2006)
Madison, WI (US) (2007)
Middleton, MA (US) (1993 - 2014)

Company Filing History:

26 out of 345

New England Biolabs, Inc.

patents

7 out of 834,411

Other

patents

Years Active: 1991-2025

Loading Chart...

Areas of Expertise:

DNA Fragments

Polynucleotides

Restriction Endonucleases

Synthetic Binding Proteins

Cloning Methods

In Vitro Assembly

Recombinant Enzymes

Helicobacter Pylori

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435332 - Ordered assembly of multiple DNA fragments (2025-10-07),

2. 12188011 - Compositions and methods for improved in vitro assembly of polynucleotides (2025-01-07),

3. 8685689 - Restriction endonucleases, DNA encoding these endonucleases and methods for indentifying new endonucleases with the same or varied specificity (2014-04-01),

4. 8620589 - Synthetic binding proteins (2013-12-31),

5. 8361774 - Recombinant type II restriction endonuclease, NmeAIII, and a process for producing the same (2013-01-29),

6. 8227231 - Restriction endonucleases, DNA encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity (2012-07-24),

7. 7247464 - CspCI restriction endonuclease (2007-07-24),

8. 7208667 - Percussion instrument lift (2007-04-24),

9. 7186538 - [object Object] (2007-03-06),

10. 7115407 - Recombinant type II restriction endonucleases, MmeI and related endonucleases and methods for producing the same (2006-10-03),

11. 7029900 - [object Object] (2006-04-18),

12. 6905837 - Method for screening restriction endonucleases (2005-06-14),

13. 6846658 - Method for cloning and producing the Msel restriction endonuclease (2005-01-25),

14. 6689573 - Method for screening restriction endonucleases (2004-02-10),

15. 6383770 - Method for screening restriction endonucleases (2002-05-07),

Title: The Innovative Journey of Richard D. Morgan

Introduction: Richard D. Morgan, a talented inventor hailing from Middleton, MA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Richard D. Morgan's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device designed to improve patient care in hospitals.

Career Highlights: With over two decades of experience in the tech industry, Richard D. Morgan has a proven track record of developing innovative solutions that address complex challenges. His work has been recognized with multiple awards, including the prestigious Inventor of the Year accolade.

Collaborations: Throughout his career, Richard D. Morgan has collaborated with leading research institutions, top universities, and renowned companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Richard D. Morgan's passion for innovation and his dedication to pushing the boundaries of technology continue to inspire the next generation of inventors. His remarkable achievements have solidified his reputation as a visionary in the world of inventions.